Skip to content
Artwork for Dr. John Campbell
Dr. John Campbell · Today · 27 min

Rapid viral evolution

BA.5, immune escape Vaccines and previous infections are protective against severe disease Percentages of positives that were infected more than 90 days ago Progressively increasing Now, 12 % reinfections 3 months ago, 8% reinfections 6 months ago, 5% reinfections https://www.youtube.com/watch?v=TwQp3Yc82ak R = 1.1 Up 27% on the week UK, 1 in 21 Scotland 1 in 15, highest ever rates Young people and young adults highest Will go up for a time, summer mixing, festivals Consistent with ONS data https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights One week ahead Hospital admissions up 37% List of covid symptoms Runny nose, 66% Sore throat, 65% Headache, 64% Persistent cough, 63% Fatigue, 62% Sneezing, 53% Hoarse, 44% Joint pains, 35% Fever, 31% Chills or shivers, 30% Muscle pains 29% Dizzy, 27% Brain fog, 24% Sore eyes, 22% Altered smell, 21% Lower back pain, 22% Swollen glands, 19% Skipped meals, 17% Chest pain, 15% BA.5 is milder than previous variants Still time off work Hospital admissions due to large numbers Official data UK https://coronavirus.data.gov.uk Coronavirus vaccines should be updated for fall https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-june-14-15-2022-meeting-announcement FDA advisory committee Deadline, vaccine formula for October, now BA.1 vaccine, in human tests for months Arnold Monto, FDA advisory committee We’re being asked, more or less, to have a crystal ball today New multi-strain vaccine, original and omicron Some wanted BA.4 and BA.5, others BA.1 Moderna, Novavax, Pfizer, each presented data to support their strategy Moderna, bivalent, for example, original version + BA.1 variant Pfizer BioNTech, only BA.1 Pfizer presented mouse data on BA.4 and BA.5 Novavax’s vaccine (not yet authorized in United States), additional doses of its existing vaccine could be protective ? will these new formulations apply to children without testing ? local or global Lyme disease Learn more about your ad choices. Visit megaphone.fm/adchoices

0:00-27:19

transcript

No transcript — this publisher did not publish one.

show notes

BA.5, immune escape Vaccines and previous infections are protective against severe disease Percentages of positives that were infected more than 90 days ago Progressively increasing Now, 12 % reinfections 3 months ago, 8% reinfections 6 months ago, 5% reinfections https://www.youtube.com/watch?v=TwQp3Yc82ak R = 1.1 Up 27% on the week UK, 1 in 21 Scotland 1 in 15, highest ever rates Young people and young adults highest Will go up for a time, summer mixing, festivals Consistent with ONS data https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights One week ahead Hospital admissions up 37% List of covid symptoms Runny nose, 66% Sore throat, 65% Headache, 64% Persistent cough, 63% Fatigue, 62% Sneezing, 53% Hoarse, 44% Joint pains, 35% Fever, 31% Chills or shivers, 30% Muscle pains 29% Dizzy, 27% Brain fog, 24% Sore eyes, 22% Altered smell, 21% Lower back pain, 22% Swollen glands, 19% Skipped meals, 17% Chest pain, 15% BA.5 is milder than previous variants Still time off work Hospital admissions due to large numbers Official data UK https://coronavirus.data.gov.uk Coronavirus vaccines should be updated for fall https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-june-14-15-2022-meeting-announcement FDA advisory committee Deadline, vaccine formula for October, now BA.1 vaccine, in human tests for months Arnold Monto, FDA advisory committee We’re being asked, more or less, to have a crystal ball today New multi-strain vaccine, original and omicron Some wanted BA.4 and BA.5, others BA.1 Moderna, Novavax, Pfizer, each presented data to support their strategy Moderna, bivalent, for example, original version + BA.1 variant Pfizer BioNTech, only BA.1 Pfizer presented mouse data on BA.4 and BA.5 Novavax’s vaccine (not yet authorized in United States), additional doses of its existing vaccine could be protective ? will these new formulations apply to children without testing ? local or global Lyme disease

Learn more about your ad choices. Visit megaphone.fm/adchoices

links1